Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer to Participate in Upcoming September Investor Conferences
04:05pm, Friday, 08'th Sep 2023
REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management
Why Shares of Seer Are Slumping Wednesday
03:12pm, Wednesday, 09'th Aug 2023
Seer CEO Omid Farokhzad said the company's sales are facing headwinds. The company lowered annual guidance for revenue.
Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates
09:11pm, Tuesday, 08'th Aug 2023
Seer, Inc. (SEER) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.37 per share a year ago.
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
04:05pm, Thursday, 13'th Jul 2023
REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it wil
Seer, Inc. (SEER) Q1 2023 Earnings Call Transcript
06:38pm, Saturday, 13'th May 2023
Seer, Inc. (NASDAQ:SEER ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - CEO, President and Chair David Horn - CFO Conference Call Pa
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
07:52pm, Tuesday, 09'th May 2023
Seer, Inc. (SEER) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.38 per share a year ago.
Seer to Report First Quarter 2023 Financial Results on May 9, 2023
04:05pm, Thursday, 20'th Apr 2023
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will repor
Seer, Inc. (SEER) Q4 2022 Earnings Call Transcript
10:32pm, Thursday, 02'nd Mar 2023
Seer, Inc. (NASDAQ:SEER ) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Carrie Mendivil – Investor Relations Omid Farokhzad – Chair, President and Chief Executive
Seer, Inc. (SEER) Reports Q4 Loss, Misses Revenue Estimates
06:49pm, Thursday, 02'nd Mar 2023
Seer, Inc. (SEER) delivered earnings and revenue surprises of 14.29% and 0.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Seer (SEER) Ahead of Earnings?
01:32pm, Wednesday, 01'st Mar 2023
Seer (SEER) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Down -26.63% in 4 Weeks, Here's Why You Should You Buy the Dip in Seer, Inc. (SEER)
11:17am, Monday, 27'th Feb 2023
Seer, Inc. (SEER) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revisin
Seer, Inc. (SEER) Moves to Buy: Rationale Behind the Upgrade
01:33pm, Thursday, 23'rd Feb 2023
Seer, Inc. (SEER) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Seer to Present at the Cowen 43rd Annual Health Care Conference
04:30pm, Tuesday, 21'st Feb 2023
REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company wi
Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
04:05pm, Thursday, 09'th Feb 2023
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report
Seer to Present at the J.P. Morgan 41st Annual Health Care Conference
04:05pm, Tuesday, 27'th Dec 2022
REDWOOD CITY, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company wi
